Skip to main content
SpringerLink
Log in

Dapagliflozin in patients with heart failure and reduced ejection fraction

  • THE CUTTING EDGE: RESEARCH UPDATE
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zinman B, Wanner C, Lachin J et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117–2122

    Article  CAS  Google Scholar 

  2. Wiviott SD, Raz I, Bonaca O et al (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 380:347–357

    Article  CAS  Google Scholar 

  3. Verma S, McMurray JJV (2018) SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review. Diabetologia 61:2108–2117

    Article  CAS  Google Scholar 

  4. McMurray JJV, Solomon SD, Inzucchi SE et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. https://doi.org/10.1056/nejmoa1911303

    Article  PubMed  Google Scholar 

  5. Riaz H, Raza S, Khan MS (2015) Impact of funding source on clinical trial results including cardiovascular outcome trials. Am J Cardiol 116:1944–1947

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento Di Medicina Interna, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy

    Giorgio Colombo

  2. UOC Pronto Soccorso e Medicina d’Urgenza, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico Di Milano, Milan, Italy

    Rosa Casella, Alessia Cazzaniga & Chiara Casiraghi

Authors
  1. Giorgio Colombo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosa Casella
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessia Cazzaniga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chiara Casiraghi
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Gruppo di Autoformazione Metodologica (GrAM)

Corresponding author

Correspondence to Giorgio Colombo.

Ethics declarations

Conflict of interest

We have no potential conflict of interest.

Statements on human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Colombo, G., Casella, R., Cazzaniga, A. et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. Intern Emerg Med 15, 515–517 (2020). https://doi.org/10.1007/s11739-020-02297-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-020-02297-0

Search

Navigation